GlassScriptPhysician profile
Kaleigh Ramey
NPI 1376311233
$2,117.00
in general payments reported to CMS, 2019-2025
20 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $823 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,097 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,096.78 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $383.11 | 2024-2025 | |
| Amgen INC. | $351.12 | 2024-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $309.88 | 2024-2025 | Verquvo |
| Boston Scientific Corporation | $187.59 | 2024-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $177.85 | 2024-2025 | Symplicity G3, Linq II |
| Shockwave Medical, INC | $90.65 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $89.06 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $83.32 | 2024-2025 | Farxiga, Airsupra |
| E.R. Squibb & Sons, L.L.C. | $67.67 | 2024-2025 | Camzyos, Eliquis |
| Lilly USA, LLC | $56.44 | 2024 | Mounjaro |
| Abbott Laboratories | $54.16 | 2024-2025 | Cardiomems |
| Abiomed | $49.32 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.02 | 2025 | Jardiance |
| Csl Behring | $34.98 | 2025 | Andembry |
| Philips North America LLC | $30.97 | 2025 | Extended Holter |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.62 | 2024 | |
| Axonics, INC. | $24.30 | 2024 | Bulkamid |
| Lexicon Pharmaceuticals, INC. | $22.14 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.62 | 2025 | Lifevest |
| W. L. Gore & Associates, INC. | $18.18 | 2024 | Gore Excluder Iliac Branch Endoprosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaleigh Ramey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.